Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Hemodynamic InstabilityPostoperative RecoveryThoracic SurgeryAnesthesia, GeneralElderly Patients
Interventions
DRUG

Esketamine

Intravenous administration of a subanesthetic dose of esketamine (0.25 mg/kg) during induction of general anesthesia. The drug was administered slowly over approximately 30 seconds after midazolam (2 mg) and sufentanil (50 µg), and prior to propofol (2 mg/kg) and rocuronium (0.6 mg/kg). The goal was to evaluate its effect on intraoperative hemodynamic stability and postoperative recovery in elderly patients undergoing thoracic surgery.

DRUG

Normal Saline (0.9% Sodium Chloride)

Intravenous administration of an equivalent volume of 0.9% normal saline during anesthesia induction, matching the timing and method of the esketamine group. Used as a placebo comparator.

DRUG

Midazolam

Intravenous administration of 2 mg midazolam during anesthesia induction for sedation. Administered prior to study drug.

DRUG

Sufentanil

Intravenous administration of 50 µg sufentanil for analgesia during anesthesia induction. Administered prior to study drug.

DRUG

propofol

Intravenous administration of 2 mg/kg propofol for loss of consciousness during anesthesia induction. Administered after study drug.

DRUG

Rocuronium

Intravenous administration of 0.6 mg/kg rocuronium to facilitate neuromuscular blockade and endotracheal intubation.

Trial Locations (1)

050011

The Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Hebei Medical University Fourth Hospital

OTHER

NCT07064408 - Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients | Biotech Hunter | Biotech Hunter